PF-Atlas › Clinical Trials › NCT03256968
PTC Study to Evaluate Ataluren in Combination With Ivacaftor
Ataluren · Phase 4
Registry ID
NCT03256968
Phase
Phase 4
Status
Completed
Drug / intervention
Ataluren
Sponsor
University of Alabama at Birmingham
Start
2017-01-27
About this trial
Ataluren is evaluated in NCT03256968, a Phase 4 idiopathic pulmonary fibrosis study sponsored by University of Alabama at Birmingham. Current status: Completed.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT03256968 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.